👤 Golnaz Vaseghi

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
3
Articles
2
Name variants
Also published as: Salar Vaseghi
articles
Marzieh Jalalian-Javadpour, Mahdi Khaledian, Hamed Moradi +4 more · 2026 · Neurotoxicity research · Springer · added 2026-04-24
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social impairments, and repetitive and aggressive behaviors. The pathophysiology of ASD still remains unclear, while th Show more
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social impairments, and repetitive and aggressive behaviors. The pathophysiology of ASD still remains unclear, while the population with ASD is 1/36 in children in the USA in 2024. Evidence suggests a wide range of inconsistent changes in brain-derived neurotrophic factor (BDNF), the most important neurotrophin in the central nervous system, in ASD. The present systematic review investigated studies that examined BDNF levels in three main ASD-like models in rodents [induced by valproic acid (VPA) and propionic acid (PPA), and in the BTBR mouse strain] in accord with PRISMA guidelines and in PubMed database. Forty-two studies were included. Most studies used male rats/mice. The results showed ASD model induced by VPA often leads to decreased BDNF, although unchanged or increased BDNF levels were also reported. ASD model induced by PPA leads to both increased and decreased BDNF. BDNF changes in BTBR mouse strain were also inconsistent. We found that the type of molecular assay appears to be important in evaluating BDNF. Also, few evidence showed a role for postnatal day and sex difference in BDNF changes in ASD-like rodent models. In addition, some studies have shown the potential role of the brain region in BDNF changes in different ASD-like models. In conclusion, it was suggested that inconsistencies in BDNF changes in rodent models of ASD may be related to the type of the molecular assay, the brain region, ASD model, sex, or even the postnatal day. However, evidence is still insufficient. Show less
📄 PDF DOI: 10.1007/s12640-026-00787-1
BDNF
Nastaran Talaee, Mahdieh Farzin Asanjan, Farnaz Hooshmand +4 more · 2026 · Learning & behavior · added 2026-04-24
Evidence has shown significant sex differences in freezing and darting behaviors in a rat model of aversive learning using fear conditioning. The present study explored sex differences in a rat model Show more
Evidence has shown significant sex differences in freezing and darting behaviors in a rat model of aversive learning using fear conditioning. The present study explored sex differences in a rat model of aversive learning using a fear-conditioning method via measuring freezing and darting behaviors. Fear conditioning was induced by three footshocks (0.8 mA, 3 s, 30-s interval) paired with an auditory conditioned stimulus (75 dB, 3 s). Extinction was performed by broadcasting 20 auditory conditioned stimuli (75 dB, 3 s, 30-s interval), with no shocks, in three, or four, of five sessions. Freezing and darting behaviors, locomotor activity and time spent in the center squares (anxiety-like behavior) in the open field test, and brain-derived neurotrophic factor (BDNF) in the infralimbic region of the mPFC (medial prefrontal cortex) were evaluated. The results showed both sexes showed a high rate of freezing, with males showing more freezing. Females were more responsive to extinction. Darting behavior was only observed in females and diminished following extinction. Locomotion and anxiety-like behavior were increased and decreased following extinction learning in both sexes, respectively. BDNF expression level in the infralimbic region of the mPFC was increased following extinction learning, with a greater increase in females. In conclusion, we showed that females have a diverse behavioral response to the anticipation of a threat in a rat model of fear conditioning. The important role of BDNF in the modulation of both freezing and darting behaviors was also shown. Show less
📄 PDF DOI: 10.3758/s13420-026-00709-3
BDNF
Shaghayegh Haghjooy Javanmard, Golnaz Vaseghi, Ahmad Ghasemi +4 more · 2020 · Cancer cell international · BioMed Central · added 2026-04-24
Melanoma is a cancer that has a high mortality rate in the absence of targeted therapy. Conventional therapies such as surgery, chemotherapy, and radiotherapy are associated with poor prognosis. The e Show more
Melanoma is a cancer that has a high mortality rate in the absence of targeted therapy. Conventional therapies such as surgery, chemotherapy, and radiotherapy are associated with poor prognosis. The expression of miR-21 appears to be of clinical importance, and the regulation of its expression appears to be an opportunity for treatment. In this current study, we aimed to evaluate the effects of miR-21 inhibition in- vitro and in-vivo. In-vitro studies have investigated LNA-anti-miR-21 in mouse melanoma cells (B16F10), and in-vivo studies have proposed a model of melanoma in male C57BL/6 mice. To evaluate the anticancer effects of LNA-anti-miR-21, a QRT-PCR analysis was performed using the 2 MiR-21 expression was inhibited by 80% after 24 h of B16F10 cell line transfection with LNA-anti-miR-21. The MTT test showed a significant reduction in the number of transfected cells with LNA-anti-miR-21. The transfected cells showed a significant increase in apoptosis in comparison with the control and scrambled LNA groups. According to our in vivo findings, anti-miR-21 could reduce tumor growth and volume in mice receiving intraperitoneal anti-miR after 9 days. The expression of the Show less
no PDF DOI: 10.1186/s12935-020-01394-6
SNAI1